Director/PDMR Shareholding

RNS Number : 0831Y
GlaxoSmithKline PLC
01 July 2008
 




Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons


I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

 

On 30 June 2008, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares at a price of £11.18 per share and ADSs at a price of $44.17 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2008 to 30 June 2008:


Non Executive Director

Ordinary Shares

American Depository Shares (ADSs)

Sir Christopher Gent

3,018.78


Prof. Sir Roy Anderson

698.79


Dr Stephanie Burns


535.49

Mr Lawrence Culp


1,070.98

Sir Crispin Davis

2,124.33


Sir Deryck Maughan


1,070.98

Dr Daniel Podolsky


704.59

Sir Ian Prosser

1,173.97


Dr Ronaldo Schmitz

849.73


Mr Tom de Swaan

698.79


Sir Robert Wilson

642.89



The Company and the Non-Executive Directors were informed of these allocations on July 2008.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).


S M Bicknell

Company Secretary

1 July 2008



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQFLFBVDBZBBQ

Companies

GSK (GSK)
UK 100